Riskpilot← Back to searchSign inGet full accessRiverFlow AB
ABActiveOrg 5590300637Frejgatan 85General medical practice activities · NACE 8621Est. 20150 employees
Revenue 2025
SEK 499K
EBITDA margin
75.5%
+12357% vs 2024
Equity ratio
61.1%
Financial strength
Net profit 2025
SEK 306K
+10065% vs 2024
| Revenue | SEK 499K | — |
| EBITDA | SEK 377K | +12357% |
| Net profit | SEK 306K | +10065% |
| Total assets | SEK 516K | +5335% |
| Equity | SEK 316K | +3222% |
| Employees | 0 | — |
Legal name
RiverFlow AB
Org number
5590300637
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
13 oktober 2015
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremålet för bolagets verksamhet är att bedriva konsultverksamhet inom läkarverksamhet och estetisk medicin.
Address
Frejgatan 85
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 499 |
| Staff expenses | — | — | — | — | −20 |
| EBITDA | −9 | −1 | −3 | −3 | 377 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −9 | −1 | −3 | −3 | 377 |
| Net financials | — | — | 0 | — | −0 |
| Profit before tax | −9 | −1 | −3 | −3 | 377 |
| Tax | −0 | — | — | — | −70 |
| Net profit | −9 | −1 | −3 | −3 | 306 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 17 | 16 | 13 | 10 | 516 |
| Equity | 17 | 16 | 13 | 10 | 316 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 0 | — | — | — | 201 |
| Total debt | — | — | — | — | 201 |
EBITDA margin
75.5%
This company
15.8%
Market median
+378% vs market
20212025
Equity ratio
61.1%
This company
38.2%
Market median
+60% vs market
20212025
Return on equity
97.0%
This company
18.4%
Market median
+427% vs market
20212025
Net profit margin
61.4%
This company
8.1%
Market median
+658% vs market
20212025
Asset turnover
0.97×
This company
1.12×
Market median
+13% vs market
20212025
Debt / equity
0.64×
This company
0.62×
Market median
+3% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TB Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (1) | ||
FM Chief Executive Officer | Chief Executive Officer | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2025 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2025 | |
| Chairman | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of RiverFlow AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fousia Mustaffa Dini | Chief Executive Officer | 0 companies |
| Tara Bakan Mhedin | Chief Executive Officer | 0 companies |
| Marian Hirzi | Deputy Board Member | 0 companies |
| Deeqa Ismail Ibrahim | Chairman | 0 companies |
| Shokan Mian | Deputy Board Member | 0 companies |